MAPT and Alzheimer disease: Glycogen synthase kinase-3 (GSK-3) is a proline-rich serine/threonine kinase and is essential in the pathogenesis of AD as it acts as a bridge between amyloid and tau; amyloid activates GSK 3, which in turn phosphorylates tau [19].